Proceedings IPFA/EBA Workshop, update as per 25 January 2020.
To promote increased plasma collection from voluntary non remunerated donors and to identify the barriers and potential solutions to achieving this objective.
The global demand for plasma for fractionation is expected to increase for the foreseeable future driven primarily by the increasing clinical use of immunoglobulin products. In this session colleagues from Belgium, Australia and Canada will describe how their strategies and policies have evolved to ensure a safe and secure national supply of plasma (both recovered and source) and PDMPs to meet patient needs – including monitoring and management of clinical use.
Without blood and plasma donors, there would be no blood products to transfuse and no plasma donations for pharmaceutical drug production. However, often as little as 2%–3% of the population is registered as blood donor and donor numbers have been decreasing over the years. At the same time, the demand for specific blood products, especially plasma-derived ones, is increasing in times of demographic change, immigration and longevity. Hence, it is crucial that a country’s donor pool is sufficient, healthy and diverse enough to ensure access to every blood type and blood product that is needed. Targeted recruitment and retention of donors with specific characteristics are key in meeting the demands and improve donor management. The aim of this session is to present evidence on donor motivation and barriers, show best practices from different countries in recruiting and retaining plasma donors and discuss ethical aspects around donor selection and blood safety.
The efficiency of the donation process to collect plasma, both source and recovered, is dependent on various factors. These factors are e.g. related to management elements, donor characteristics and technical aspects. During this session you will learn how to optimise the management of the collection process, personnel and the efficiency of the donation and processing of blood and plasma.
This session will provide opportunity for industries providing equipment, materials and support to blood centres and establishments to present on technical and scientific developments in their companies in support of the goal of increased plasma supply.
Plasma donors often donate frequently. With the scale-up of plasma donation it is of paramount importance to assure that the procedure is safe. In this session we will present the knowledge on short and long term effects of plasmapheresis. We will also discuss what knowledge is missing and what studies we need to perform.
The collection and preparation of blood components and plasma for fractionation are highly regulated activities requiring comprehensive quality management systems to meet the standards prescribed by regulatory authorities and the plasma fractionation industry. This session will consider specific quality requirements for plasma intended for fractionation from the perspectives of both regulators and manufacturers together with a discussion of the wider benefits of plasma quality programmes for blood establishments.
This session will share the experiences from European, Australian and Canadian Blood establishments of their current development and future plans for the efficient and cost effective large scale collection of recovered and source plasma from VNRDs. The aim of the session will be to identify key considerations for the development of infrastructure and logistical arrangements to optimize capacity, efficiency, cost effectiveness and donor experience.